Clinical trial
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
NCT02918357 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 15, 2016
- Completion date
- September 21, 2017
- Enrollment
- 385 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer